How to adjust ACE inhibitors and ARBs in diabetes?
Authors:
- MdMDMd
- 1 May 2004
- journal article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 115 (5) , 9-10
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trialThe Lancet, 2002
- Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetesCurrent Hypertension Reports, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Type 2 Diabetes: RENAAL and IDNT—The Emergence of New Treatment OptionsThe Journal of Clinical Hypertension, 2002
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- ELITE II and Val-HeFT are different trials: together what do they tell us?Trials, 2001
- Angiotensin-Converting Enzyme Inhibitor–Associated Elevations in Serum CreatinineArchives of internal medicine (1960), 2000
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudyThe Lancet, 2000